CA2319542A1 - The treatment of sexual dysfunction in certain patient groups - Google Patents
The treatment of sexual dysfunction in certain patient groups Download PDFInfo
- Publication number
- CA2319542A1 CA2319542A1 CA002319542A CA2319542A CA2319542A1 CA 2319542 A1 CA2319542 A1 CA 2319542A1 CA 002319542 A CA002319542 A CA 002319542A CA 2319542 A CA2319542 A CA 2319542A CA 2319542 A1 CA2319542 A1 CA 2319542A1
- Authority
- CA
- Canada
- Prior art keywords
- sexual dysfunction
- patient groups
- treatment
- certain patient
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Abstract
Methods for treating specific patient groups for sexual dysfunction are provided. The methods of the present invention comprise the utilization of pharmaceutical compositions in patients who are free of cardiac disease and/or who have not been given organic nitrates.
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/071,457 US6110489A (en) | 1998-05-01 | 1998-05-01 | Use of quinolines and quinolones to treat male erectile dysfunction |
US09/166,703 US6194433B1 (en) | 1998-10-05 | 1998-10-05 | Sexual dysfunction in females |
US09/175,395 US6132753A (en) | 1998-05-01 | 1998-10-19 | Treatment of sexual dysfunction in certain patient groups |
US09/260,099 US6132757A (en) | 1998-05-01 | 1999-03-02 | Treatment of sexual dysfunction in certain patient groups |
US09/175,395 | 1999-03-04 | ||
US09/262,715 US6187790B1 (en) | 1999-03-04 | 1999-03-04 | Use of cilostazol for treatment of sexual dysfunction |
US09/071,457 | 1999-03-04 | ||
US09/262,715 | 1999-03-04 | ||
US09/166,703 | 1999-03-04 | ||
US09/260,099 | 1999-03-04 | ||
PCT/US1999/009610 WO1999056666A1 (en) | 1998-05-01 | 1999-04-30 | The treatment of sexual dysfunction in certain patient groups |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2319542A1 true CA2319542A1 (en) | 1999-11-11 |
CA2319542C CA2319542C (en) | 2005-07-12 |
Family
ID=27535884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002319542A Expired - Fee Related CA2319542C (en) | 1998-05-01 | 1999-04-30 | The treatment of sexual dysfunction in certain patient groups |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1079764A4 (en) |
JP (1) | JP2002537231A (en) |
AU (1) | AU3780699A (en) |
BR (1) | BR9908716A (en) |
CA (1) | CA2319542C (en) |
MX (1) | MXPA00010254A (en) |
WO (1) | WO1999056666A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6403597B1 (en) | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
US6548490B1 (en) * | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
US6541487B1 (en) * | 1998-05-01 | 2003-04-01 | R.T. Alamo Ventures I, Llc | PDE III inhibitors for treating sexual dysfunction |
WO2002058703A2 (en) * | 2001-01-26 | 2002-08-01 | R.T. Alamo Ventures I, Llc | The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers |
US6730790B2 (en) | 2002-03-01 | 2004-05-04 | R.T. Alamo Ventures I. Llc | Chlorinated heterocyclic compounds and methods of synthesis |
US6767914B2 (en) | 2002-03-01 | 2004-07-27 | R.T. Alamo Ventures I, Llc | Fluorinated heterocyclic compounds and methods of synthesis |
US6727262B2 (en) | 2002-03-01 | 2004-04-27 | R.T. Alamo Ventures I, Llc | Dichlorinated heterocyclic compounds and methods of synthesis |
US7041677B2 (en) | 2002-03-01 | 2006-05-09 | R.T. Alamo Ventures I, Llc | Use of monochloroflosequinan in the treatment of sexual dysfunction |
GB0208704D0 (en) * | 2002-04-16 | 2002-05-29 | Futura Medical Dev Ltd | Condom |
TWI323660B (en) * | 2003-02-25 | 2010-04-21 | Otsuka Pharma Co Ltd | Pten inhibitor or maxi-k channels opener |
TWI338583B (en) | 2004-05-20 | 2011-03-11 | Otsuka Pharma Co Ltd | Solid pharmaceutical formulation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4801587A (en) * | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
DE4117249C2 (en) * | 1991-05-27 | 1998-05-14 | Christian Dr Stief | Linsidomine used to treat erectile dysfunction |
EP0651640A1 (en) * | 1992-07-21 | 1995-05-10 | Knoll AG | Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris |
GB9301192D0 (en) * | 1993-06-09 | 1993-06-09 | Trott Francis W | Flower shaped mechanised table |
AU5509099A (en) * | 1998-08-03 | 2000-02-28 | Basf Corporation | Pyridinones for the treatment of sexual dysfunction |
-
1999
- 1999-04-30 AU AU37806/99A patent/AU3780699A/en not_active Abandoned
- 1999-04-30 JP JP2000599185A patent/JP2002537231A/en not_active Withdrawn
- 1999-04-30 EP EP99920266A patent/EP1079764A4/en not_active Withdrawn
- 1999-04-30 CA CA002319542A patent/CA2319542C/en not_active Expired - Fee Related
- 1999-04-30 WO PCT/US1999/009610 patent/WO1999056666A1/en not_active Application Discontinuation
- 1999-04-30 MX MXPA00010254A patent/MXPA00010254A/en not_active IP Right Cessation
- 1999-04-30 BR BR9908716-2A patent/BR9908716A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2319542C (en) | 2005-07-12 |
AU3780699A (en) | 1999-11-23 |
WO1999056666A1 (en) | 1999-11-11 |
MXPA00010254A (en) | 2002-08-06 |
EP1079764A4 (en) | 2001-09-12 |
EP1079764A1 (en) | 2001-03-07 |
JP2002537231A (en) | 2002-11-05 |
BR9908716A (en) | 2000-11-21 |
WO1999056666A8 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267381A (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
WO2004019884A3 (en) | Agents and methods for enhancing bone formation | |
CA2184916A1 (en) | Use of fibroblast growth factors to stimulate bone growth | |
HUT60630A (en) | Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature | |
IL112664A0 (en) | 4-amino derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them | |
CA2373794A1 (en) | Compositions and uses of et743 for treating cancer | |
CA2319542A1 (en) | The treatment of sexual dysfunction in certain patient groups | |
CA2294921A1 (en) | Levobupivacaine and its use | |
BR9813318A (en) | Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient | |
DE69521536T2 (en) | Compositions containing G-CSF and a TNF binding protein | |
HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
AU8020698A (en) | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain | |
HUP0302538A3 (en) | 3,7-diazabicyclo[3.3.0]oczanes and their use in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them | |
DE69939075D1 (en) | Pharmaceutical composition for the prevention and treatment of diseases associated with cell diseases of the fundus | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
WO1999065475A3 (en) | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction | |
EP0821969A3 (en) | Medicinal Composition comprising TCF-II | |
CA2290739A1 (en) | New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy | |
MA26648A1 (en) | THERAPEUTIC COMBINATIONS FOR THE TREATMENT OF BONE DISEASES, AND METHOD FOR THEIR PREPARATION. | |
WO2000078800A3 (en) | Combined decorin binding protein and outer surface protein compositions and methods of use | |
CA2097878A1 (en) | Therapeutic agent for neutropenia | |
CA2309653A1 (en) | Use of protein h as cytostatic agent | |
UA32241A (en) | Method for treating inflammations in experiment | |
AU2002300509A1 (en) | The Treatment of Sexual Dysfunction in Certain Patient Groups | |
RU93014293A (en) | METHOD OF TREATMENT OF CHRONIC BRONCHITIS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |